Blockade of PD-1 signaling by anti-PD-L1 antibody reduced leukemia cell burden in AML mice, at least partly by inhibiting the expansion of PD-1+ Treg cells and reversing inhibitory cytokine production. Here, CD274 is linked to acute myeloid leukemia.